But this is reporting ischemia or not.
Hasn't the previous focus, and previous sensitivity/specificity, been on bleed or not?
I guess the company is now moving towards a full use POC scanner rather than just a haemorrhagic stroke excluder. Or did I miss something?
Ann: Enhanced Algorithm Performance From Continuous Innovation, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
0.010(0.56%) |
Mkt cap ! $153.9M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.85 | $1.80 | $78.92K | 43.10K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 608 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.85 | 2250 | 2 |
View Market Depth
| Last trade - 13.42pm 16/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |